Summary: The legal dispute initiated on August 22, 2023, centers around NJOY, LLC, a Delaware-based firm specializing in electronic nicotine products, and JUUL Labs, Inc. (JLI), another corporation from Delaware. The crux of the matter is an alleged patent infringement by JLI. NJOY asserts that JLI has violated two of its patents, specifically United States Patent Nos. 10,334,881 ('881) and 11,497,864 ('864), both pertaining to electronic vaporizer technology. These patents outline a device comprising a cartridge and a power source, with distinctive features like an airflow passageway and a heating element to vaporize a solution. NJOY contends that JLI's JUUL system, which incorporates a disposable cartridge and a device equipped with a battery and circuitry, infringes on these patents. NJOY accuses JLI of direct infringement through the manufacture, use, sale, and importation of the JUUL system. Moreover, NJOY alleges that JLI has incited others to infringe on their patents by promoting the use of the JUUL device and providing usage instructions. Additionally, NJOY accuses JLI of contributing to the infringement by supplying or selling the JUUL device and/or the JUUL pod, which they argue are integral to the asserted claims of the '864 patent. NJOY maintains that JLI's infringement is deliberate and that despite being aware of the '864 patent and its infringement, JLI continues their infringing activities. NJOY is seeking a permanent injunction against JLI to halt further infringement of the '864 patent, along with damages to compensate for all infringement up to the date of judgment, including prejudgment interest, and any supplemental damages deemed appropriate, as well as post-judgment interest. They are also requesting a declaration that this infringement action is an exceptional case under 35 U.S.C. § 285 and an award of reasonable counsel fees and costs. The case is currently being adjudicated in the United States District Court for the District of Delaware.